Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Shalaby

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
JHEP Reports : Innovation in Hepatology|February 22, 2024
Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlookedPol Olivas, Valeria Perez-Campuzano, Lara Orts, et al.
Thrombosis and Haemostasis|July 1, 2020
Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of CirrhosisSarah Shalaby, Paolo Simioni, Elena Campello, et al.
JHEP Reports : Innovation in Hepatology|October 10, 2025
Isolation and immortalization of human portal vein endothelial cells: A novel research tool for studying splanchnic vasculatureAina Anton, Sarah Shalaby, Júlia Campalans, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 26, 2017
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antiviralsAlberto Zanetto, Sarah Shalaby, Alessandro Vitale, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2025
Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trialValeria Perez-Campuzano, Pol Olivas, José Ferrusquía-Acosta, et al.
JHEP Reports : Innovation in Hepatology|December 3, 2024
Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individualsGeorg Semmler, Oleksandr Petrenko, Juanjo Jose Lozano, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2024
Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradientPol Olivas, Alexandre Soler-Perromat, Luis Tellez, et al.
International Journal of Cancer|August 10, 2018
Survival after the diagnosis of de novo malignancy in liver transplant recipientsMartina Taborelli, Pierluca Piselli, Giuseppe Maria Ettorre, et al.
International Journal of Cancer|April 26, 2018
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014Martina Taborelli, Pierluca Piselli, Giuseppe Maria Ettorre, et al.
Hepatology (Baltimore, Md.)|October 27, 2025
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosisAina Anton, Sarah Shalaby, María Luisa Botero, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
JHEP Reports : Innovation in Hepatology|February 22, 2024
Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlookedPol Olivas, Valeria Perez-Campuzano, Lara Orts, et al.
Thrombosis and Haemostasis|July 1, 2020
Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of CirrhosisSarah Shalaby, Paolo Simioni, Elena Campello, et al.
JHEP Reports : Innovation in Hepatology|October 10, 2025
Isolation and immortalization of human portal vein endothelial cells: A novel research tool for studying splanchnic vasculatureAina Anton, Sarah Shalaby, Júlia Campalans, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 26, 2017
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antiviralsAlberto Zanetto, Sarah Shalaby, Alessandro Vitale, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2025
Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trialValeria Perez-Campuzano, Pol Olivas, José Ferrusquía-Acosta, et al.
JHEP Reports : Innovation in Hepatology|December 3, 2024
Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individualsGeorg Semmler, Oleksandr Petrenko, Juanjo Jose Lozano, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2024
Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradientPol Olivas, Alexandre Soler-Perromat, Luis Tellez, et al.
International Journal of Cancer|August 10, 2018
Survival after the diagnosis of de novo malignancy in liver transplant recipientsMartina Taborelli, Pierluca Piselli, Giuseppe Maria Ettorre, et al.
International Journal of Cancer|April 26, 2018
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014Martina Taborelli, Pierluca Piselli, Giuseppe Maria Ettorre, et al.
Hepatology (Baltimore, Md.)|October 27, 2025
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosisAina Anton, Sarah Shalaby, María Luisa Botero, et al.
Pageof 6